Telia M Extended-Release Tablet 10/750 mg

Adult dose

This medication is typically administered once daily with the evening meal. The 20/1000 mg extended-release tablet is taken once daily at a dose of 1 tablet. The 10/750 mg or 10/500 mg extended-release tablets are taken once daily at a dose of 2 tablets simultaneously. The initial dosage consists of 20 mg of teneligliptin once daily and the previous dosage of metformin. The maximum recommended daily dosage is 20 mg of teneligliptin and 2000 mg of extended-release metformin.

This medication is used for the treatment of diabetes and helps regulate blood sugar levels. This medication should not be administered to patients with impaired kidney function, especially in cases of moderate to severe renal impairment. It is safe not to use this medication for patients with acute heart disease, heart failure, severe infections, or liver dysfunction. Before examinations using radiolabeled iodine contrast agents, this medication should be discontinued at least 48 hours prior, and its use can be resumed only after confirming that kidney function is normal. Pregnant women or those who may become pregnant should not take this medication, and it is also not recommended for breastfeeding mothers. When used in conjunction with other diabetes medications, careful monitoring of blood sugar levels is necessary to prevent hypoglycemia. Rarely, this medication can cause a serious condition known as lactic acidosis, which is extremely dangerous, so patients should inform their doctor immediately if symptoms occur. During treatment, gastrointestinal symptoms, dizziness, skin rashes, etc., may occasionally appear, so if any abnormal symptoms arise, consult a healthcare professional. In elderly patients, kidney function should be regularly checked, and doses should be adjusted as necessary. In case of overdose, immediate medical care should be sought, and blood dialysis may be required. This medication has not been proven safe and effective for children, so do not use it for pediatric patients. It is advisable to avoid alcohol consumption during treatment, especially excessive drinking, as it can increase the risk of lactic acidosis. This medication may interact with certain drugs, so if other medications are being taken, it is essential to inform healthcare providers. Patients should be well-informed about hypoglycemia symptoms and how to address them during treatment, and appropriate actions should be taken immediately if symptoms appear. If blisters or skin abnormalities occur, consult a doctor immediately, and drug discontinuation and professional treatment may be necessary. Keep this medication out of the reach of children, and do not transfer it to other containers.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blistering, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, decreased urine output.

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• abdominal distension
• abdominal discomfort
• nausea
• abdominal pain
• bloating
• stomatitis
• gastric polyps

This medication should be stored in a tightly sealed container to prevent air ingress and is best kept at room temperature between 1 degree and 30 degrees Celsius. Storing this way helps maintain the medication's effectiveness for a long time.

Appearance

Yellow egg-shaped extended-release film-coated tablet

Package unit

Domestic use - 30 tablets/bottle